ProfileGDS5678 / 1418473_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 63% 64% 64% 64% 66% 63% 62% 63% 64% 64% 64% 64% 63% 66% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.8033563
GSM967853U87-EV human glioblastoma xenograft - Control 23.8097864
GSM967854U87-EV human glioblastoma xenograft - Control 33.7995564
GSM967855U87-EV human glioblastoma xenograft - Control 43.7901864
GSM967856U87-EV human glioblastoma xenograft - Control 53.952266
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8588263
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.8070162
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.7689663
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.8037264
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.8090264
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.8038364
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.8035664
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.8077663
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.9425666